IOF Iofina plc
Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, mineral separators, specialty intermediates, thyroid health, wound healing, diagnostic imaging, iofina logo gray sun 5, preservatives and sanitizers, semiconductor etchant gas, soil fumigants, fine halogen chemicals, electronic specialty gases, and heat stabilizers applications. The company markets its products in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, nylon, x-ray contrast media industries. It serves animal nutrition, biocidal paints and coatings, disinfectants, x-ray contrast media, pharmaceuticals, electronics, perovskites for solar, optical polarizing films, industrial, oil and gas industries. The company sells its products under the IOflo and IOprill brand names. Iofina plc was incorporated in 2005 and is based in London, the United Kingdom.…
Industry Peers
Specialty ChemicalsKey Statistics
About Iofina (LON: IOF)
›
Iofina (LON: IOF) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 126 employees.
The shares were at 48.00 GBp on 20 November 2026, up 114.3% over 52 weeks. Its 52-week range is 20.00 GBp to 60.12 GBp: the price is 20.2% below the high and 140.0% above the low.
At a market capitalisation of 92.09M GBP, it trades at 16.0 times trailing earnings and 9.5 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 33.6, a discount of 52% for IOF.
Iofina reports return on equity of 14.1%, an operating margin of 17.2% and revenue up 7.4% year over year.
It holds more cash than debt, a net cash position of 6.52M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 70.00 GBp is 45.8% above the current price.